Dublin, July 10, 2023 (GLOBE NEWSWIRE) -- The "Recombinant Proteins Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.
This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
The rising prevalence and incidence of chronic illnesses, technological innovation, and expanding R&D investments by key companies are the primary drivers driving the growth of the recombinant proteins market. Increased awareness of chronic illnesses among the general public and governments is predicted to improve the market for recombinant goods. According to the World Health Organisation (WHO), chronic illnesses are the leading cause of mortality worldwide, accounting for over 60% of all fatalities.
The increased frequency of chronic illnesses is one of the major factors impacting the market. Diabetes, cancer, respiratory disorders, and cardiovascular disease are only a handful of the most common chronic diseases. According to Globocan forecasts, the number of cancer cases would rise from 19.3 million in 2020 to 24.6 million in 2030.
Furthermore, by 2030, there will be 587 million diabetics globally. Chronic illnesses account for over 80% of mortality in middle- and low-income countries. Chronic illnesses are expected to affect more than 49% of the population in the U.S. by 2025. Strokes and heart problems account for 30% of all fatalities in the U.S.
Market Dynamics
Drivers
- Rising Demand for Recombinant Products
- High Funding for Biomedical Research
- Increase in Number of Elderly Population will Drive the Market Growth
- Patent Expiration for Biologics
Restraints
- Price Erosion of Recombinant Proteins
- Stringent Regulation for Recombinant Proteins Production
Opportunities
- Emerging Economies Expansion and Prioritisation of R&D
- Growing Significance of Genomics and Proteomics
What Questions Should You Ask before Buying a Market Research Report?
- How is the recombinant proteins market evolving?
- What is driving and restraining the recombinant proteins market?
- How will each recombinant proteins submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each recombinant proteins submarket develop from 2023 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading recombinant proteins markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the recombinant proteins projects for these leading companies?
- How will the industry evolve during the period between 2023 and 2033? What are the implications of recombinant proteins projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the recombinant proteins market?
- Where is the recombinant proteins market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
Segments Covered in the Report
Product & Services Outlook
- Products
- Cytokines & Growth Factors: Interferons (IFNs), Interleukins (ILs), Others
- Antibodies
- Enzymes: Kinases Enzymes, Metabolic Enzymes, Others
- Recombinant Regulatory Protein
- Hormones
- Virus Antigens
- Immune Checkpoint Proteins
- Others
- Services
Application Outlook
- Biopharmaceutical Production
- Biologics
- Vaccines
- Cell & Gene Therapies
- Others
- Drug Discovery & Development
- Research
- Diagnostics
- Others
Host Cell Outlook
- Mammalian Systems
- Bacterial Cells
- Yeast & Fungi
- Insect Cells
- Others
End-user Outlook
- Biopharmaceutical and Biotechnology Companies
- CROs
- Academic & Research Institutes
- Diagnostic Laboratories
- Others
Leading companies and the potential for market growth
- Abcam Plc
- Abnova Corporation
- Avantor Inc.
- Bio-Rad Laboratories, Inc.
- Bio-Techne
- Enzo Biochem Inc.
- GenScript
- Merck KGaA
- PerkinElmer, Inc.
- Proteintech Group, Inc.
- RayBiotech Life, Inc.
- Sino Biological Inc.
- STEMCELL Technologies
- Thermo Fisher Scientific Inc.
Overall world revenue for Recombinant Proteins Market, 2023 to 2033 in terms of value the market will surpass US$3,079.9 million in 2023, this work calculates. We predict strong revenue growth through to 2033. this work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Recombinant Proteins Market, 2023 to 2033 report help you?
In summary, this 350+ page report provides you with the following knowledge:
- Revenue forecasts to 2033 for Recombinant Proteins Market, 2023 to 2033 Market, with forecasts for product & services, application, host cell, end-user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for five regional and 22 key national markets - See forecasts for the Recombinant Proteins Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 14 of the major companies involved in the Recombinant Proteins Market, 2023 to 2033.
For more information about this report visit https://www.researchandmarkets.com/r/h9jz2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
